Andrew Corkum heads the international business for QuidelOrtho across Europe, Middle East, Africa and Latin America regions. He brings more than 30 years of international sales and operational leadership experience with expertise in transfusion medicine and in vitro diagnostics.

Mr. Corkum joined the company in 2017 as President of Commercial Operations in Canada. Previously, he was with Immucor as Vice President of Sales for Europe and Canada. He began his career in immunodiagnostics with Dominion Biologicals. Before his current role with QuidelOrtho, he served as global head of the clinical labs and transfusion medicine business units where he oversaw all activities related to portfolio strategy and innovation, product development, life cycle management, market development, marketing and portfolio growth.

Mr. Corkum received a bachelor’s degree in business administration from Mount Saint Vincent University and an MBA in international business from Athabasca University.